Inflammation in the CNS: Understanding Various Aspects of the Pathogenesis of Alzheimer's Disease

Overview

Journal Curr Alzheimer Res

Publisher Bentham Science Publishers

Specialty Neurology

Date 2021 Dec 3

PMID 34856902

Citations 5

Authors

Julia Doroszkiewicz

Piotr Mroczko

Agnieszka Kulczynska-Przybik

Affiliations

Soon will be listed here.

Abstract

Alzheimer's disease is a progressive and deadly neurodegenerative disorder and one of the most common causes of dementia globally. Current, insufficiently sensitive and specific methods of early diagnosing and monitoring this disease prompt a search for new tools. Numerous literature data have indicated that the pathogenesis of Alzheimer's disease (AD) is not limited to the neuronal compartment but involves various immunological mechanisms. Neuroinflammation has been recognized as a very important process in AD pathology. It seems to play pleiotropic roles, both neuroprotective and neurodegenerative, in the development of cognitive impairment depending on the stage of the disease. Mounting evidence demonstrates that inflammatory proteins could be considered biomarkers of disease progression. Therefore, the present review summarizes the role of some inflammatory molecules and their potential utility in detecting and monitoring dementia severity. This paper also provides a valuable insight into new mechanisms leading to the development of dementia, which might be useful in discovering possible anti-inflammatory treatment.

Citing Articles

p38α Mitogen-Activated Protein Kinase-An Emerging Drug Target for the Treatment of Alzheimer's Disease.

Detka J, Plachtij N, Strzelec M, Manik A, Salat K Molecules. 2024; 29(18).

PMID: 39339348 PMC: 11433989. DOI: 10.3390/molecules29184354.

Epigenetic Regulation of Neuroinflammation in Alzheimer's Disease.

Ma Y, Wang W, Liu S, Qiao X, Xing Y, Zhou Q Cells. 2024; 13(1).

PMID: 38201283 PMC: 10778497. DOI: 10.3390/cells13010079.

Molecular Aspects of a Diet as a New Pathway in the Prevention and Treatment of Alzheimer's Disease.

Doroszkiewicz J, Mroczko J, Rutkowski P, Mroczko B Int J Mol Sci. 2023; 24(13).

PMID: 37445928 PMC: 10341644. DOI: 10.3390/ijms241310751.

Impact of asthma on the brain: evidence from diffusion MRI, CSF biomarkers and cognitive decline.

Nair A, Van Hulle C, Bendlin B, Zetterberg H, Blennow K, Wild N Brain Commun. 2023; 5(3):fcad180.

PMID: 37377978 PMC: 10292933. DOI: 10.1093/braincomms/fcad180.

New Possibilities in the Therapeutic Approach to Alzheimer's Disease.

Doroszkiewicz J, Mroczko B Int J Mol Sci. 2022; 23(16).

PMID: 36012193 PMC: 9409036. DOI: 10.3390/ijms23168902.

References

Rogers J, Morganti J, Bachstetter A, Hudson C, Peters M, Grimmig B . CX3CR1 deficiency leads to impairment of hippocampal cognitive function and synaptic plasticity. J Neurosci. 2011; 31(45):16241-50. PMC: 3236509. DOI: 10.1523/JNEUROSCI.3667-11.2011. View

Kiyota T, Gendelman H, Weir R, Higgins E, Zhang G, Jain M . CCL2 affects β-amyloidosis and progressive neurocognitive dysfunction in a mouse model of Alzheimer's disease. Neurobiol Aging. 2012; 34(4):1060-8. PMC: 4011558. DOI: 10.1016/j.neurobiolaging.2012.08.009. View

Okuda M, Fujita Y, Hijikuro I, Wada M, Uemura T, Kobayashi Y . PE859, A Novel Curcumin Derivative, Inhibits Amyloid-β and Tau Aggregation, and Ameliorates Cognitive Dysfunction in Senescence-Accelerated Mouse Prone 8. J Alzheimers Dis. 2017; 59(1):313-328. DOI: 10.3233/JAD-161017. View

Hua Y, Guo X, Huang Q, Kong Y, Lu X . Association between interleukin-6 -174G/C polymorphism and the risk of Alzheimer's disease: a meta-analysis. Int J Neurosci. 2013; 123(9):626-35. DOI: 10.3109/00207454.2013.784286. View

Griciuc A, Serrano-Pozo A, Parrado A, Lesinski A, Asselin C, Mullin K . Alzheimer's disease risk gene CD33 inhibits microglial uptake of amyloid beta. Neuron. 2013; 78(4):631-43. PMC: 3706457. DOI: 10.1016/j.neuron.2013.04.014. View

Blanco-Palmero V, Rubio-Fernandez M, Antequera D, Villarejo-Galende A, Molina J, Ferrer I . Increased YKL-40 but Not C-Reactive Protein Levels in Patients with Alzheimer's Disease. Biomedicines. 2021; 9(9). PMC: 8467854. DOI: 10.3390/biomedicines9091094. View

Tang Y, Le W . Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases. Mol Neurobiol. 2015; 53(2):1181-1194. DOI: 10.1007/s12035-014-9070-5. View

Abate G, Vezzoli M, Polito L, Guaita A, Albani D, Marizzoni M . A Conformation Variant of p53 Combined with Machine Learning Identifies Alzheimer Disease in Preclinical and Prodromal Stages. J Pers Med. 2020; 11(1). PMC: 7823360. DOI: 10.3390/jpm11010014. View

Asby D, Boche D, Allan S, Love S, Miners J . Systemic infection exacerbates cerebrovascular dysfunction in Alzheimer's disease. Brain. 2021; 144(6):1869-1883. PMC: 8320299. DOI: 10.1093/brain/awab094. View

10.

Bonham L, Karch C, Fan C, Tan C, Geier E, Wang Y . CXCR4 involvement in neurodegenerative diseases. Transl Psychiatry. 2018; 8(1):73. PMC: 5893558. DOI: 10.1038/s41398-017-0049-7. View

11.

Chee S, Solito E . The Impact of Ageing on the CNS Immune Response in Alzheimer's Disease. Front Immunol. 2021; 12:738511. PMC: 8484764. DOI: 10.3389/fimmu.2021.738511. View

12.

Decourt B, Lahiri D, Sabbagh M . Targeting Tumor Necrosis Factor Alpha for Alzheimer's Disease. Curr Alzheimer Res. 2016; 14(4):412-425. PMC: 5328927. DOI: 10.2174/1567205013666160930110551. View

13.

Schafer D, Stevens B . Microglia Function in Central Nervous System Development and Plasticity. Cold Spring Harb Perspect Biol. 2015; 7(10):a020545. PMC: 4588063. DOI: 10.1101/cshperspect.a020545. View

14.

Sanfilippo C, Castrogiovanni P, Imbesi R, Nunnari G, Di Rosa M . Postsynaptic damage and microglial activation in AD patients could be linked CXCR4/CXCL12 expression levels. Brain Res. 2020; 1749:147127. DOI: 10.1016/j.brainres.2020.147127. View

15.

Bhaskar K, Konerth M, Kokiko-Cochran O, Cardona A, Ransohoff R, Lamb B . Regulation of tau pathology by the microglial fractalkine receptor. Neuron. 2010; 68(1):19-31. PMC: 2950825. DOI: 10.1016/j.neuron.2010.08.023. View

16.

Zenaro E, Pietronigro E, Della Bianca V, Piacentino G, Marongiu L, Budui S . Neutrophils promote Alzheimer's disease-like pathology and cognitive decline via LFA-1 integrin. Nat Med. 2015; 21(8):880-6. DOI: 10.1038/nm.3913. View

17.

Webers A, Heneka M, Gleeson P . The role of innate immune responses and neuroinflammation in amyloid accumulation and progression of Alzheimer's disease. Immunol Cell Biol. 2019; 98(1):28-41. DOI: 10.1111/imcb.12301. View

18.

Zhang Z, Zhang Z, Lu H, Yang Q, Wu H, Wang J . Microglial Polarization and Inflammatory Mediators After Intracerebral Hemorrhage. Mol Neurobiol. 2016; 54(3):1874-1886. PMC: 4991954. DOI: 10.1007/s12035-016-9785-6. View

19.

Khanna S, Park H, Sen C, Golakoti T, Sengupta K, Venkateswarlu S . Neuroprotective and antiinflammatory properties of a novel demethylated curcuminoid. Antioxid Redox Signal. 2008; 11(3):449-68. PMC: 2787730. DOI: 10.1089/ars.2008.2230. View

20.

Rentzos M, Zoga M, Paraskevas G, Kapaki E, Rombos A, Nikolaou C . IL-15 is elevated in cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia. J Geriatr Psychiatry Neurol. 2006; 19(2):114-7. DOI: 10.1177/0891988706286226. View